RxDoctor Payments DataLook up a doctor →

Russell Snyder, MD

Family Medicine · Huntington, WVNPI 1366635112

Payments from drug & device makers

$14,705in general payments, 2019–2025

Across 1,022 payments — averaging $14.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$2K
  • Novartis$1K
  • Novo Nordisk$1K
  • GSK$1K
  • Lilly USA, LLC$799
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,696100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)76$1,779
AbbVie(2 entities)116$1,512
Novartis99$1,378
Novo Nordisk135$1,347
GSK82$1,226
Lilly USA, LLC41$799
Amgen50$724
E.r. Squibb & Sons, L.L.C.66$698
Boehringer Ingelheim40$478
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC39$469
Amarin Pharma, Inc.28$392
Takeda Pharmaceuticals U.S.A., Inc.19$308
Esperion Therapeutics, Inc.17$242
Pfizer12$223
Paratek Pharmaceuticals, Inc.12$222
Bayer10$218
Argenx US, Inc.12$209
Otsuka America Pharmaceutical, Inc.15$194
Vifor Pharma, Inc.15$187
Teva Pharmaceuticals USA, Inc.11$171
Shield Therapeutics Inc7$147
Biohaven Pharmaceuticals, Inc.9$140
Avanir Pharmaceuticals, Inc.20$138
Johnson & Johnson(2 entities)10$137
Daiichi Sankyo Inc.6$116
Biohaven Pharmaceutical Holding Company Ltd.6$103
Sunovion Pharmaceuticals Inc.6$97
Kowa Pharmaceuticals America, Inc.7$95
Abbott5$92
Intercept Pharmaceuticals, Inc.5$77
Sanofi-aventis U.S. LLC4$66
Merck2$44
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$44
Melinta Therapeutics, LLC3$43
Mylan Specialty L.p.2$42
Tactile Systems Technology Inc1$42
Lundbeck LLC2$34
Phathom Pharmaceuticals, Inc.3$33
Smith+Nephew2$33
Shire North American Group Inc2$29
Genentech USA, Inc.2$29
Aurinia Pharma U.S., Inc.1$28
Corcept Therapeutics2$26
Endo Pharmaceuticals Inc.2$24
Philips North America LLC1$23
Xeris Pharmaceuticals, Inc.1$22
Insulet Corporation1$21
Baxter Healthcare1$21
Scpharmaceuticals Inc.1$19
Exact Sciences1$18
Advanced Respiratory, Inc1$17
Sanofi Pasteur Inc.1$16
Organon1$16
Boston Scientific1$14
Ironwood Pharmaceuticals, Inc1$14
Astellas Pharma US Inc1$14
Abiomed1$14
Eisai Inc.1$14
Neurocrine Biosciences, Inc.1$13
Therapeuticsmd, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,705 in reported general payments places this provider in the 95th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$187,976
Medicare patients
547
Services billed
2,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide313$379,775
EliquisApixaban301$298,869
XareltoRivaroxaban184$202,894
JardianceEmpagliflozin129$167,066
OzempicSemaglutide119$137,694
JanuviaSitagliptin Phosphate88$99,905
FarxigaDapagliflozin Propanediol46$50,921
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$49,867
EntrestoSacubitril/Valsartan34$31,775
TrulicityDulaglutide27$29,087
LinzessLinaclotide27$26,985
RybelsusSemaglutide18$23,535
Repatha SureclickEvolocumab34$21,677
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$12,680
MyrbetriqMirabegron14$11,502

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$799$408,862340 claims
PfizerEliquis, Premarin$223$306,359314 claims
Johnson & JohnsonXarelto$137$202,894184 claims
Boehringer IngelheimJardiance$478$167,066129 claims
Novo NordiskOzempic, Rybelsus$1,347$161,229137 claims
MerckJanuvia$44$99,90588 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,779$58,82958 claims
GSKTrelegy Ellipta$1,226$49,86748 claims
NovartisEntresto$1,378$31,77534 claims
AbbVieLinzess, Synthroid$1,512$30,917107 claims
Astellas Pharma US IncMyrbetriq$14$11,50214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →